Compounds > 2,2',2''-trichlorotriethylamine
Page last updated: 2024-11-05

2,2',2''-trichlorotriethylamine and Adenocarcinoma, Basal Cell

2,2',2''-trichlorotriethylamine has been researched along with Adenocarcinoma, Basal Cell in 2 studies

2,2',2''-trichlorotriethylamine: RN given refers to parent cpd; structure

Research Excerpts

ExcerptRelevanceReference
" Besides, in 21% of the rats receiving the dosage of 0."1.26Carcinogenicity of trichloromethine hydrochloride (TS-160 Spofa) and morphological damage after its intraamniotic injection. ( Dynterová, A; Marhan, O; Sýkora, I; Vortel, V, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sýkora, I1
Vortel, V1
Marhan, O1
Dynterová, A1

Reviews

1 review available for 2,2',2''-trichlorotriethylamine and Adenocarcinoma, Basal Cell

ArticleYear
Trichlorotriethylamine hydrochloride.
    IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, 1975, Volume: 9

    Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma 256, Walker; Chromosome Aberrations; Drug Evaluation

1975

Other Studies

1 other study available for 2,2',2''-trichlorotriethylamine and Adenocarcinoma, Basal Cell

ArticleYear
Carcinogenicity of trichloromethine hydrochloride (TS-160 Spofa) and morphological damage after its intraamniotic injection.
    Neoplasma, 1981, Volume: 28, Issue:5

    Topics: Adenocarcinoma; Alkylating Agents; Animals; Colonic Neoplasms; Dose-Response Relationship, Drug; Fem

1981